600867.SHG Tonghua Dongbao Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
8.00 CNY
Close of Nov 4, 2026
7.16 10.67
Market cap
CNY 15.7B
P/E
28.6x
P/B
2.20x
ROE
9.9%
Dividend yield
3.22%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600867.SHG undervalued?

Graham number
Price8.00
Graham value4.78
Premium67.2%

600867.SHG trades 67.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tonghua Dongbao Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Tonghua Dongbao Pharmaceutical Co Ltd yet.

Tonghua Dongbao Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tonghua Dongbao Pharmaceutical Co Ltd

Tonghua Dongbao Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of biological products, traditional Chinese medicines, chemical medicines, and other drugs in China and internationally. The company offers liraglutide injections; insulin glargine injections; insulin aspart injections; human insulin injections; isophane protamine human insulin injections; mixed protamine human insulin injections; suganning cap…

Full company profile